. 1973 Oct 25;248(20):7242-6.

NH2-terminal sequences of mammalian plasminogens and plasmin S-carboxymethyl heavy (A) and light (B) chain derivatives. A re-evaluation of the mechanism of activation of plasminogen

Free article

K C Robbins et al. J Biol Chem. 1973.

Free article

. 1973 Oct 25;248(20):7242-6.

No abstract available

Cited by

Amino-acid sequence of activation cleavage site in plasminogen: homology with "pro" part of prothrombin.
Sottrup-Jensen L, Zajdel M, Claeys H, Petersen TE, Magnusson S. Sottrup-Jensen L, et al. Proc Natl Acad Sci U S A. 1975 Jul;72(7):2577-81. doi: 10.1073/pnas.72.7.2577. Proc Natl Acad Sci U S A. 1975. PMID: 1058475 Free PMC article.
Extracellular matrix destruction by invasive tumor cells.
Jones PA, De Clerck YA. Jones PA, et al. Cancer Metastasis Rev. 1982;1(4):289-317. doi: 10.1007/BF00124214. Cancer Metastasis Rev. 1982. PMID: 6224552 Review.
The plasminogen-plasmin system in malignancy.
Kwaan HC. Kwaan HC. Cancer Metastasis Rev. 1992 Nov;11(3-4):291-311. doi: 10.1007/BF01307184. Cancer Metastasis Rev. 1992. PMID: 1423820 Review.
The human plasma fibrinolytic system: regulation and control.
Robbins KC. Robbins KC. Mol Cell Biochem. 1978 Aug 16;20(3):149-57. doi: 10.1007/BF00243761. Mol Cell Biochem. 1978. PMID: 151804 Review.
The primary inhibitor of plasmin in human plasma.
Müllertz S, Clemmensen I. Müllertz S, et al. Biochem J. 1976 Dec 1;159(3):545-53. doi: 10.1042/bj1590545. Biochem J. 1976. PMID: 137718 Free PMC article.